EtiAmmos/iStock via Getty Images
- GRAIL (NASDAQ:GRAL) and Quest Diagnostics (NYSE:DGX) on Wednesday announced the initial phase of a collaborative effort to improve the provider access to the former’s Galleri multi-cancer early detection test.
- Under the partnership, healthcare providers will be able to directly order the
